Psychedelic Medicine Association: Increasing access to ketamine therapy

This is a presentation I gave for the Psychedelic Medicine Association and it’s centered around how we, as a community of providers, can help expand access to ketamine not only across the country, but globally. I share my own personal experience becoming involved with ketamine and how I've expanded my practice since then. I also explain the main ways we work with ketamine at Novamind, including Ketamine-Assisted Psychotherapy (KAP), Ketamine-Assisted Psychotherapy (KAP), and Ketamine or Spravato as a medical intervention, and I delve into the differences and what each of these entail. We’ve learned a lot and have developed some remarkable methods for utilizing these psychedelics in treatment.

As an FYI, this is geared towards providers, but could be useful for others who might be interested in learning about ketamine therapy. Also, an account with the Psychedelic Medicine Association is required to access the presentation. Feel free to check it out at the link below.